SUMMARY Fifty four sexual partners of homosexual men with the acquired immune deficiency syndrome (AIDS) were studied, ofwhom 32 were seropositive and 22 seronegative for human T cell lymphotropic virus type III or lymphadenopathy virus (HTLV-III/LAV) antibody, which showed that repeated exposure by anal intercourse does not necessarily lead to seroconversion. Seropositivity to HTLV-III/LAV was not associated with the absolute number of sexual partners, receptive anal intercourse, or the use of recreational drugs, but was associated with a history of other sexually transmitted diseases (STDs), particularly in the year preceding the patient's initial examination. Acquisition of an STD after the date of last sexual contact with a person with AIDS was strongly associated (p<001) with the development of persistent generalised lymphadenopathy (PGL). Concurrent or recent STDs would seem to be an important cofactor in developing antibody to HTLV-III/LAV and in the progression of infection from a person being asymptomatic to having PGL.
Introduction
Human T lymphotropic virus type III or lymphadenopathy virus (HTLV-III/LAV) has now been established as the causative agent ofthe acquired immune deficiency syndrome (AIDS) and related disorders."3 Serological studies in many centres have shown that the presence of antibody to HTLV-II/ LAV is strongly associated with AIDS and persistent generalised lympadenopathy (PGL).4s CheingsongPopov et al in a study of2000 serum samples in Britain showed that only 42% (15/36) of the male sexual partners of homosexual men with AIDS were seropositive for HTLV-III/LAV.' Geodert et al showed in a cohort study that risk factors for acquiring antibody to HTLV-IIV/LAV included a large number of sexual partners and receptive anal intercourse. 7 Melbye in a study of250 Danish homosexual men showed that the incidence of receptive anal intercourse was a highly significant factor in seropositivity, but the number of Address for reprints: DrA J Pinching, DepartmentofImmunology, St Mary's Hospital Medical School, London W2 IPG Accepted for publication 17 March 1986 sexual partners was not an independent risk factor. 8 Gazzard et al also noted that 3/19 sexual partners of patients with AIDS were seronegative, but did not analyse further the factors associated with seropositivity.9 This prospective study ofsexual partners of patients with AIDS was designed specifically to investigate the risk factors for sexual acquisition of HTLV-III/LAV, as assessed by serology, in an exposed population.
Patients and methods
We selected 54 homosexual men, all of whom had had sexual intercourse with a patient subsequently diagnosed as having AIDS (by the criteria of the Centers for Disease Control). Intercourse had been either anal insertive or receptive (or both), and had occurred on at least four occasions in the two years preceding the diagnosis ofAIDS. None ofthe contacts was a user ofintravenous drugs or a haemophiliac, and none had received any blood products, including gamma globulin or hepatitis B vaccine.
Of the sexual contacts, 34 were the current sexual partners of patients with AIDS seen at this hospital and 20 were past regular partners traced by the stan- Table I shows the results of studies of sexual behaviour and history of STDs in the two groups. The difference between the two groups in the type of sexual intercourse was not significant. The seropositive groups, however, had had significantly (p<0-01) more STDs during their lives and in the year preceding examination, which in effect represented the time of exposure to the patient with AIDS.
The association between passive anal intercourse and seropositivity was not significant in this study. Three seropositive men had a lifelong history of active The study published here has shown that STD may be an important cofactor in infection with HTLV-II/ J N Weber, A McCreaner, E Berrie, et al LAV. Clearly, any intercurrent infection may lead to T cell activation. STDs were chosen for this study because their documentation was readily available. The possible role of other infections must now be assessed. Meanwhile, the implications for counselling patients are clear. HTLV-III/LAV infected people should avoid intercurrent infection; this strengthens the need for a reduction in sexual partners by infected patients. Varying rates or types of intercurrent infection, for example in central Africa, may be responsible for the differing rates of progression to AIDS in infected patients.
